GLP-1 vs SGLT2: The New Frontier in Diabetes Therapy
A new commentary in The Lancet examines whether oral GLP-1 receptor agonists can match SGLT2 inhibitors in cardiovascular and kidney protection for type 2 diabetes.
Read the full articleYou might also wanna read
GLP-1 Agonists May Help People With Diabetes and Long COVID
People with type 2 diabetes face increased risk of severe lung conditions. A new study reported that mice treated with GLP-1agonists showed
GLP-1 Receptor Agonists and Alzheimer's Disease: A Multi-National Target Trial Emulation
Conditions : Alzheimer Disease; Diabetes Mellitus Type 2; Obesity & Overweight Interventions : Drug: GLP-1 Receptor Agonists; Drug: DPP-4 In
Can GLP-1 medications improve health in people with Type 2 diabetes and PAD?
Research Highlights: GLP-1RA (glucagon-like peptide-1 receptor agonist) medications, which are prescribed to treat Type 2 diabetes and to he
Research Suggests Heart Disease, Kidney Disease and Type 2 Diabetes May Be One Condition Treatable with GLP-1 Drugs
These three disorders could really be “CKM syndrome,” which can be treated with drugs like Ozempic
scientificamerican.com·6mo ago
Biased Dual-Agonists of GLP-1 and Glucagon Receptors Developed Through Conserved Aspartate Mutation
Peptide agonists of the glucagon-like peptide 1 receptor (GLP-1R) have demonstrated clinical efficacy for the management of type 2 diabetes
go.acs.org·12d ago
Conflicts of interest threaten integrity of GLP-1 therapy guidance amid rapid adoption
Stronger safeguards are needed to ensure independent and transparent recommendations Glucagon-like peptide-1 (GLP-1) receptor agonists and r
bmj.com·20d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.